<DOC>
	<DOCNO>NCT02839954</DOCNO>
	<brief_summary>The purpose study evaluate safety effectiveness CAR-pNK cell immunotherapy patient MUC1 positive relapse refractory solid tumor .</brief_summary>
	<brief_title>CAR-pNK Cell Immunotherapy MUC1 Positive Relapsed Refractory Solid Tumor</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>Male female subject MUC1+ malignancy patient available curative treatment option limit prognosis ( several month &lt; 2 year survival ) currently available therapy enrol : 1 . Eligible disease : MUC1+ malignant glioma brain , colorectal carcinoma , gastric carcinoma , hepatocellular carcinoma , nonsmall cell lung cancer , pancreatic carcinoma triplenegative basallike breast carcinoma . 2 . Patients 18 year age old , must life expectancy &gt; 12 week . 3 . MUC1 express malignancy tissue immunohistochemical ( IHC ) . 4 . Eastern cooperative oncology group ( ECOG ) performance status 02 karnofsky performance status ( KPS ) score high 60 . 5 . Presence measurable disease RECIST . 6 . Females childbearing potential must negative pregnancy test subject must agree use effective method contraception two week last infusion CARpNK cell . 7 . Adequate bone marrow , liver renal function assess follow laboratory requirement : White blood cell count ( WBC ) ≥ 2500c/ml , Platelets ≥ 50×10^9/L , Hb ≥ 9.0g/dL , lymphocyte ( LY ) ≥ 0.7×10^9/L , LY % ≥ 15 % , Alb ≥ 2.8g/dL , serum lipase amylase &lt; 1.5×upper limit normal , serum creatinine ≤ 2.5mg/dL , aspartate aminotransferase ( AST ) alanine aminotransferase ( ALT ) ≤ 5×upper limit normal , serum total bilirubin ≤ 2.0mg/dL . These test must conduct within 7 day prior registration . 8 . Ability give inform consent . 1 . Patients symptomatic central nervous system ( CNS ) involvement . 2 . Pregnant nursing woman may participate . 3 . Active HIV , hepatitis B virus ( HBV ) hepatitis C virus ( HCV ) infection . 4 . Serious illness medical condition would permit patient manage accord protocol , include active uncontrolled infection , major cardiovascular , coagulation disorder , respiratory immune system , myocardial infarction , cardiac arrhythmia , obstructive/restrictive pulmonary disease , psychiatric emotional disorder . 5 . Concurrent use systemic steroid . Recent current use inhale steroid exclusionary . 6 . The existence unstable active ulcer gastrointestinal bleeding . 7 . Patients history organ transplantation wait organ transplantation . 8 . Patients need anticoagulant therapy ( warfarin heparin ) . 9 . Patients need longterm antiplatelet therapy ( aspirin dose &gt; 300mg/d ; clopidogrel dose &gt; 75mg/d ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>